Picture of Rubius Therapeutics logo

RUBY — Rubius Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

IFR's upcoming US IPOs, follow-ons + convertibles

Near term pipeline of notable IPOs, follow-ons and convertible
offerings, from IFR and other sources:
    
    ** Jul 12: Spero Therapeutics  SPRO.O  (US, biotech) – $75m
FO & CVT. 3.25m shs, cvt pfd stock into 2.2m shs (100% prim) vs
$13.85 revised filing, $17.39 last sale @ launch. COWN, STFL,
CANT. Deal extended from Jul 11
    ** Jul 12: Cytomx Therapeutics  CTMX.O  (US, biotech) –
$125m FO. Shs TBD (100% prim) vs $24.63 last sale @ launch. GS,
CITI, BARC
    ** Jul 12: Myovant Sciences  MYOV.N  (Switzerland, biotech)
– $75m FO. Shs TBD (100% prim) vs $24.10 last sale @ launch.
JPM, GS, BARC
    ** Jul 17: Crinetics Pharmaceuticals (US, biotech) – $85m
IPO. 5m shs (100% prim), range $15-$17. JPM, LEER, PJ. Nasdaq
"CRNX"
    ** Jul 18: AFG  AFGL.N  (US, E&P equipment) – $328m IPO.
18.2m shs (30% prim), range $15-$18. GS, CS, SIMM, BARC, EVER,
UBS, WF
    ** Jul 18: Allakos (US, biotech) – $102m IPO. 6m shs (100%
prim), range $15-$17. GS, JEFF. Nasdaq "ALLK"
    ** Jul 18: Constellation Pharmaceuticals  CNST.O  (US,
biotech) – $85m IPO. 5.34m shs (100% prim), range $14-$16. JPM,
JEFF, BMO
    ** Jul 18: Establishment Labs (British Virgin Islands,
medtech) – $53m IPO. 3.13m shs (100% prim), range $15-$17. JEFF,
COWN. Nasdaq "ESTA"
    ** Jul 18: Rubius Therapeutics (US, biotech) – $210m IPO.
9.53m shs (100% prim), range $20-$22. JPM, MS, JEFF, LEER.
Nasdaq "RUBY"
    ** Jul 18: Tilray  TLRY.O  (US/Canada, medical cannabis
cultivation) – $144m IPO. 9m shs (100% prim), range $14-$16.
COWN, ROTH, NORTH. Includes Canadian offering
    ** Jul 18: First Western Financial (US, bank) - $39m IPO.
1.85m shs (81% prim), range $19-$21. KBW, STEPH, SAND
    ** Jul 19: Replimune (US, biotech) – $107m IPO. 6.7m shs
(100% prim), range $14-$16. JPM, LEER, BMO. Nasdaq "REPL"
    ** Jul 24: Bloom Energy (US, fuel cells) – $270m IPO. 18m
shs (100% prim), range $13-$15. JPM, MS, CS, KEYB, BAML. NYSE
"BE"

 ((lance.tupper.tr.com@reuters.net
lance.tupper@tr.com 646-223-5017))

Recent news on Rubius Therapeutics

See all news